In this issue:
- Serial vs current liver stiffness measurements to predict decompensation
- Long-term tenofovir disoproxil fumarate increases fracture risk
- Empagliflozin for metabolic dysfunction-associated steatotic liver disease
- Mycophenolate mofetil for remission induction in autoimmune hepatitis
- Long-term efficacy of a recombinant hepatitis E vaccine
- Protective function of sclerosing cholangitis on IBD
- Survodutide for MASH and fibrosis
- Addressing hepatitis C-related stigma and discrimination
- Hepatitis C virus screening in mental health settings
- Models for prediction of liver fibrosis in chronic hepatitis B
Please login below to download this issue (PDF)